Bio-Techne
TECH
#1562
Rank
A$16.76 B
Marketcap
$105.50
Share price
3.54%
Change (1 day)
8.90%
Change (1 year)
Bio-Techne Corporation is an American holding company for biotechnology and clinical diagnostic brands. The company's brands portfolio includes R&D Systems, Novus Biologicals, Tocris Bioscience, ProteinSimple, Exosome Diagnostics, BiosPacific, Cliniqa, Advanced Cell Diagnostics, RNA Medical, Bionostics and BostonBiochem.

Bio-Techne (TECH) - Total liabilities

Total liabilities on the balance sheet as of September 2024 : A$0.91 Billion

According to Bio-Techne's latest financial reports the company's total liabilities are A$0.91 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Bio-Techne - Total liabilities on balance sheet (from 2001 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-06-30A$1.01 B17.66%
2022-06-30A$0.86 B-6.26%
2021-06-30A$0.92 B-2.13%
2020-06-30A$0.94 B-8.11%
2019-06-30A$1.02 B47.4%
2018-06-30A$0.69 B-12.3%
2017-06-30A$0.79 B136.33%
2016-06-30A$0.33 B18.79%
2015-06-30A$0.28 B295.12%
2014-06-30A$71.38 M60.88%
2013-06-30A$44.37 M1.26%
2012-06-30A$43.82 M48.52%
2011-06-30A$29.5 M45.81%
2010-06-30A$20.23 M5.09%
2009-06-30A$19.25 M-8.86%
2008-06-30A$21.12 M4.04%
2007-06-30A$20.3 M-50%
2006-06-30A$40.6 M13.12%
2005-06-30A$35.9 M-11.56%
2004-06-30A$40.59 M1.69%
2003-06-30A$39.91 M-29.38%
2002-06-30A$56.52 M-23.6%
2001-06-30A$73.99 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
A$78.70 B 8,481.83%๐Ÿ‡บ๐Ÿ‡ธ USA
A$4.78 B 421.56%๐Ÿ‡บ๐Ÿ‡ธ USA
A$45.61 B 4,873.99%๐Ÿ‡บ๐Ÿ‡ธ USA
A$44.99 B 4,806.53%๐Ÿ‡บ๐Ÿ‡ธ USA
A$3.34 B 264.83%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
A$165.17 B 17,911.54%๐Ÿ‡บ๐Ÿ‡ธ USA
A$45.52 M-95.04%๐Ÿ‡บ๐Ÿ‡ธ USA